.
Cochlear Limited (ASX:COH) has recorded a fall in EBIT 54% for the first half of Fiscal 2014, falling from $108.3 million in H1 2013 to $49.4 million for H1 this year.
Net profit fell similar a percentage between the periods, from $77.7 million to $36.8 million.
The company said in an announcement that regulatory approval was still outstanding on a number of new products, slowing their release while also depressing sales of existing products.
Despite the regulatory difficulties, new lines of product were released in Q2 and sales improved 30% over Q1.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$319.42 |
Change
2.420(0.76%) |
Mkt cap ! $20.88B | |||
| Open | High | Low | Value | Volume |
| $317.80 | $319.56 | $315.50 | $38.61M | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72 | $318.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $319.50 | 27 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |